Bacillus coagulans GBI-30, 6086 and Reduced Soluble CD163 Level

• Immunomodulation of antiretroviral drug-suppressed chronic HIV-1 infection in an oral probiotic double-blind placebo-controlled trial.

  • 2014-10
  • RCT
  • AIDS research and human retroviruses 30(10)
  • • Otto O Yang
    • Theodoros Kelesidis
    • Robert Cordova
    • Homayoon Khanlou

  • PubMed: 25127924
  • DOI: 10.1089/aid.2014.0181

  9 Insights on

  • Reduced Soluble CD163 Level

  • High evidence
  • Clinical

  borderline for a greater sCD163 drop in the probiotic versus placebo group, p=0.05

  Effect

  Neutral

  Effect size

  Small

  Significant

  No

  Dose

  1 capsule (presumed, exact probiotic concentration not stated in abstract)